Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nitroglycerin vs Labetalol for Tissue Perfusion in Sinus Surgery
NCT03809065Phase 4Completed
- Sponsor
- Cairo University
- Start
- Jan 2019
- Primary completion
- May 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of nitroglycerin, labetalol in paranasal sinus disease, sponsored by Cairo University. Started Jan 2019; status: completed.
02
Drugs
nitroglycerinlabetalol
03
Conditions
paranasal sinus disease
Beyond the preview
Go deeper on NCT03809065.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03809065.